Cargando…
Fast-Acting Insulin Aspart: The Rationale for a New Mealtime Insulin
Attenuating postprandial hyperglycaemia is a critical factor in the achievement of optimal glucose control. Prandial insulin analogues have been developed to replicate the physiology of normal endogenous insulin secretion and action, with the aim of limiting postprandial glucose excursions. There is...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Healthcare
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6778592/ https://www.ncbi.nlm.nih.gov/pubmed/31485918 http://dx.doi.org/10.1007/s13300-019-00685-0 |